Conferences & Events
2024
16-18 October - GMP Symposium - Lyon, France
Our Senior Pharmacometrician, Pauline Bambury, presented the poster "Accelerating Drug Development Using the InSilicoTrials Platform for Design and Evaluation of Clinical Studies" at the GMP 2024 Symposium in Lyon, which brought together industry experts for valuable discussions.
15 October - Life Science Informatics Forum - Milan, Italy
InSilicoTrials participated in the Life Science Informatics Forum on October 15, 2024, where our CEO, Luca Emili, presented โThe Power of LLMs in Next-Gen In Silico Drug Development,โ focusing on AI-driven technologies transforming drug development.
10 October - Stockholm-Uppsala Pharmacometrics - Uppsala, Sweden
Our VP of R&D, Daniel Rรถshammar, presented on "Mechanistic Modeling of Blood-Brain Barrier Breakdown and Drug Repair" at the Stockholm-Uppsala Pharmacometrics fall meeting in Uppsala, Sweden, focusing on semi-mechanistic models based on PK and/or PD data.
9-10 October - BioTechX Europe - Basel, Switzerland
InSilicoTrials headed to Basel, where colleagues Sofia Stathopoulos and John Varaklis presented a poster on "Speeding Up Literature Search for Diversity Action Plans with AI" at BioTechX Europe, one of the world's leading biotechnology congresses.
8 October - DayOne's Exclusive Healthtech Forum - Basel, Switzerland
Our CEO, Luca Emili, participated in an exclusive forum with TH KIM and Jochen Hurlebaus to discuss collaboration between startups and pharma in healthtech and medtech, fostering connections with investors and industry leaders.
3 October - Health Horizons: Investment Strategies for a New Era in Healthcare and Life Sciences - Paris, France
AI and Big Data reshaped the future of healthcare at the โHealth Horizons: Investment Strategies for a New Era in Healthcare and Life Sciencesโ conference, featuring our CEO, Luca Emili, on a distinguished panel.
25-27 September - SMASH-HCM Plenary Meeting - Rennes, France
Alessia Baretta and Vincenzo Carbone, Ph.D., attended the SMASH-HCM plenary meeting in Rennes, collaborating with over 40 partners on the EU-funded digital-twin platform for hypertrophic cardiomyopathy, where InSilicoTrials will integrate the Decision Support System on our cloud platform.
17-18 September - DPHARM - Philadephia, USA
We were proud finalists at DPHARM Idol Disrupt 2024, where our COO, Mario Torchia, and MaryAnne Rizk, Ph.D., showcased InSilicoTrials' in silico technology for drug development, congratulating Power on their win and recognizing fellow participants Beaconcure, ThoughtSphere, Inspire, and ProofPilot.
17-18 September - BioTechX USA 2024 - Philadelphia, USA
Sofia Stathopoulos presented at BioTechX on using AI to streamline literature searches for FDA's Diversity Action Plans, reducing hours of manual work to minutes and promoting health equity.
16 September - Workshop AICRO, Associazione Italian CRO - Rome, Italy
Our CEO, Luca Emili, was a key speaker at a workshop hosted by AICRO, where he discussed critical developments in Decentralized Clinical Trials (DCTs) and the strategic use of virtual patients and synthetic control arms to accelerate research and development processes.
11-12 September - ECCPM Forum - Graz, Austria
InSilicoTrials participated in the ECCPM Forum 2024 on September 11-12 at the University of Technology Graz, where CEO Luca Emili presented "Hyper Accelerate R&D with In Silico Trials," highlighting how advanced modeling and simulation are transforming pharmaceutical development.
9-10 September - DeCODe Project Kick-Off meeting - Brussels, Belgium
Meeting the partners of the DeCODE project last week highlighted how InSilicoTrials' expertise in digital health innovation and Good Simulation Practice will support the development of safe pediatric and orphan medical devices for children with rare diseases.
4-6 September - VPH Conference 2024 - Stuttgart, Germany
At the VPH2024 Conference in Stuttgart, Alessia Baretta presented the SimCardioTest EU project on next-gen cardiac care, and Vincenzo Carbone, PhD shared best practices for simulation in regulatory processes, highlighting our contributions to the future of healthcare.
15-16 July - EDITH-CSA Final Ecosystem Meeting: Building the Virtual Human Twin - Amsterdam, The Netherlands
At the FDA CTTI AI Workshop, InSilicoTrials' CEO Luca Emili highlighted their AI-driven, GSP-compliant simulation models that accelerate Quality by Design by 90%, reduce traditional studies, and promote transparency, while also introducing "Medical Constitutional AI" for explainable, reliable outcomes and a rapid literature review tool supporting FDAโs Diversity Action Plan.
29-31 July - 4th annual mRNA-Based Therapeutics Summit - Boston, USA
InSilicoTrials attended the 4th Annual mRNA-Based Therapeutics Summit in Boston, where they showcased innovative tools like the Clinical Trial Simulator and InSilico Vaccine Suite to enhance trial efficiency and support mRNA therapeutic development.
15-16 July - EDITH-CSA Final Ecosystem Meeting: Building the Virtual Human Twin - Amsterdam, The Netherlands
In the final EDITH-CSA ecosystem meeting, the Virtual Human Twin (VHT) roadmap was updated, with industry advisors like InSilicoTrials contributing input for validation and final recommendations to ensure the initiative's success.
26-28 June - PAGE Population Approach Group Europe - Rome, Italy
Our team participated in the PAGE - Population Approach Group Europe 2024 conference in Rome, where we engaged with the community and presented our latest advancements.
16-19 June - DIA Global Annual Meeting - San Diego, USA
Our team took part in the DIA 2024 Global Annual Meeting in San Diego, where we organized the session titled "Are Human Patients Needed for Clinical Trials, Tomorrow?" This engaging panel featured Jonathan Helfgott, Adam Kaplin, and our CEO, Luca Emili, and was moderated by MaryAnne Rizk, Ph.D.
3-6 June - Bio International Convention - San Diego, USA
Our team, including Luca Emili, Mario Torchia, and Sofia Stathopoulos, had an exceptional experience at the BIO International Convention. Engaging with numerous professionals and companies, we laid the groundwork for promising future collaborations.
12-14 May - BioEquity Europe - San Sebastiร n, Spain
We participated in BioEquity Europe 2024 in San Sebastiรกn, Spain. Our CEO, Luca Emili, led a company presentation, showcasing the benefits of integrating AI with computational modeling and simulation for biotech research.
16-17 April - Bio-IT World Conference & Expo - Boston, USA
Our team, including Michael Eckstut, MaryAnne Rizk, Ph.D., and Mario Torchia, participated in the Bio-IT World Conference & Expo 2024, where they presented the poster titled "Demonstrating the Use of Modeling and Simulation with InSilicoTrials' Biosimulation Platform."
10-11 April - BOOM Summit - Basel, Switzerland
We participated in the BOOM Summit, a leading event in healthcare innovation. Our booth facilitated meaningful exchanges on the latest advancements. Highlights included our CEO, Luca Emili, presenting at the "Innovation Showcase" and being selected among the top three startups to pitch on the main stage.
27-29 March - ASCPT - Colorado Springs, USA
Mark Lovern presented an insightful poster on Population Pharmacokinetics (PK) and Pharmacodynamics (PD) analyses of multiple intravenous infusions of NX210c peptide in Healthy Elderly Volunteers (HEVs) at the ASCPT 2024 Annual Meeting.
20 March - Swisscom Ventures Digital Health Day - Bern, Switzerland
Luca Emili, our CEO, took the stage as a speaker at Swisscom Ventures Digital Health Day 2024 on March 20th. He provided an overview of our advanced AI and Modeling and Simulation platform designed to predict clinical trial outcomes. His presentation showcased our innovative solutions and was well-received by the audience.
28 February - ECHAlliance - Woman's Health Session - Barcelona, Spain
Our colleague Vincenzo Carbone was a speaker at the Woman's Health Session where it was explored the crucial role of women in healthcare, delving into the innovative world of FemTech, and addressing pressing issues like accessibility and bias in womenโs health data.
20 February - InSilicoMinds Workshop
Dr. Daniel Rรถshammar, VP of R&D at InSilicoTrials, & Dr. Pranav Karmwar, Chief Scientific Officer of InSilicoMinds, talked on harnessing AI, modeling & simulation to maximize regulatory impact & compliance.
11 -14 February - SCOPE Summit - Orlando, Florida
We are excited to announce that InSilicoTrials was among the selected finalists for the Clinical Trial Tech's inaugural Start-Up Pitch Contest, a highlight of the SCOPE summit 2024.
6 - 7 February - InnovaHeart - Leuven, Belgium
Our colleague Alessia introduced the audience to the latest developments within the SimCardioTest EU project eHealth_EU project, offering the first public glimpse of the digital environment designed for three use cases in cardiac care, in collaboration with our European partners.
9 January 2024 - RESI Conference JMP - San Francisco, USA
Happy New Year! As we step into 2024 , ๐๐ป๐ฆ๐ถ๐น๐ถ๐ฐ๐ผ๐ง๐ฟ๐ถ๐ฎ๐น๐ is excited to kickstart the year by announcing our participation in the prestigious Redefining Early Stage Investments - ๐ฅ๐๐ฆ๐ ๐๐ฃ๐ ๐ฎ๐ฌ๐ฎ๐ฐ.